J. O'Leary et al., Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?, J CL PATH-M, 53(2), 2000, pp. 69-76
Citations number
29
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Aims-Human herpesvirus 8 (HHV-8) has been identified in multicentric Castle
man's disease and in angioimmunoblastic lymphadenopathies. However, the pre
sence of the virus does not necessarily indicate an aetiological role in th
ese conditions. This study investigates the cell types infected by HHV-8 in
Castleman's disease and examines the correlation between HHV-8 and Castlem
an's disease lymph node angiogenesis.
Methods-Sixteen formalin fixed, paraffin wax embedded samples from patients
with Castleman's disease (six multicentric, 10 solitary) were examined for
the presence of HHV-8 using the polymerase chain reaction (PCR), non-isoto
pic in situ hybridisation, PCR in situ hybridisation (PCR-ISH), and real ti
me quantitative TaqMan PCR to HHV-8 open reading frame 26 (ORF-26), and vir
al (v)-cyclin encoding regions. Vascularity was assessed using CD34, CD31,
and factor VIII immunocytochemistry, and lymph nodes were scored as "low" o
r "high".
Results-Five multicentric Castleman's disease and two solitary Castleman's
disease biopsies were positive for HHV-8. HHV-8 was identified in approxima
tely 10% of intranodal B lymphocytes, in endothelial cells, and in subcapsu
lar spindle cell proliferations. The copy number of HHV-8 was low at 10-50
copies/1000 cells. The highest copy number was in subcapsular spindle cells
. There was no correlation between vascularity score and HHV-8 status.
Conclusion-The preferential localisation of HHV-8 in subcapsular spindle ce
ll proliferations (where early intranodal Kaposi's sarcoma initiates) and e
ndothelial cells in Castleman's disease might finally explain the link betw
een intranodal Kaposi's sarcoma and Castleman's disease.